Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

IDH mutation status trumps the Pignatti risk score as a prognostic marker in low-grade gliomas.

Journal of neuro-oncology - 1 Nov 2017

Etxaniz Olatz, Carrato Cristina, de Aguirre Itziar, Queralt Cristina, Muñoz Ana, Ramirez José L, Rosell Rafael, Villà Salvador, Diaz Rocio, Estival Ana, Teixidor Pilar, Indacochea Alberto, Ahjal Sara, Vilà Laia, Balañá Carme

Abstract excerpt

Management of low-grade gliomas (LGG) is based on clinical and radiologic features, including the Pignatti prognostic scoring system, which classifies patients as low- or high-risk. To determine whether molecular data can offer advantages over these features, we have examined the prognostic impact of several molecular alterations in LGG. In a cohort of 58 patients with LGG, we have retrospectively analyzed...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Brain Neoplasms
Share to Follow-Up Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Glioma

Share to Isocitrate Dehydrogenase

Share to Multivariate Analysis

Share to Neoplasm Grading

Share to Risk Assessment

Share to Survival Analysis

Source

Identifiers

PMID: 28884377
DOI: 10.1007/s11060-017-2570-1

Genes

MGMT

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

IDH mutation status trumps the Pignatti risk score as a prognostic marker in low-grade gliomas.PMID 28884377Read ↗

Imaging scoring systems for preoperative molecular diagnoses of lower-grade gliomas.Semantic proximity Read ↗

The role of clinical and molecular factors in low-grade gliomas: what is their impact on survival?Semantic proximity Read ↗

IDH/MGMT-driven molecular classification of low-grade glioma is a strong predictor for long-term survival.Semantic proximity Read ↗

Thirty years of progress in the management of low-grade gliomas.Semantic proximity Read ↗

IDH1 or IDH2 mutations predict longer survival and response to temozolomide in low-grade gliomas.Semantic proximity Read ↗

Current management of low-grade gliomas.Semantic proximity Read ↗

Radiological characteristics based on isocitrate dehydrogenase mutations and 1p/19q codeletion in grade II and III gliomas.Semantic proximity Read ↗

Predictive and prognostic factors for gliomas.Semantic proximity Read ↗

Molecular subtype classification of low-grade gliomas using magnetic resonance imaging-based radiomics and machine learning.Semantic proximity Read ↗

Advances in molecular and imaging biomarkers in lower-grade gliomas.Semantic proximity Read ↗

Molecular genetics of adult grade II gliomas: towards a comprehensive tumor classification system.Semantic proximity Read ↗

A population-based study of low-grade gliomas and mutated isocitrate dehydrogenase 1 (IDH1).Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.